https://www.gosh.nhs.uk/our-research/our-research-infrastructure/nihr-great-ormond-street-hospital-brc/brc-news/?page=37

Biomedical Research Centre news

Autolus acquires rights to commercialise novel T-cell therapy developed at GOSH and UCLH

24 Apr 2018, 2:56 p.m.

The biopharmaceutical company Autolus has acquired global rights to develop and commercialize a novel T-cell therapy for the treatment of B-cell lymphomas and leukaemias.

A woman at work in a lab, looking into a microscope.

London consortium secures £5 million to drive world-class university commercialisation

24 Apr 2018, 12:15 p.m.

The National Institute for Health Research (NIHR) GOSH Biomedical Research Centre (BRC) is part of a new £5 million consortium led by Kings College London which will strengthen London’s status as a world centre of commercialisation in medical technologies

New sequencing method can diagnose bone abnormalities in fetuses

22 Apr 2018, 5:10 p.m.

Research led by Professor Lyn Chitty has shown that prenatal exome sequencing in fetuses can provide accurate and timely molecular diagnoses for skeletal conditions and inform pregnancy management.

NIHR GOSH BRC spinout Orchard Therapeutics signs strategic agreement with GSK

13 Apr 2018, 1:10 p.m.

GSK and Orchard Therapeutics today announced a strategic agreement, under which GSK will transfer its portfolio of approved and investigational rare disease gene therapies to Orchard, securing the continued development of the programmes and access for pat

UK-wide consortium to transform treatment for children and young people with arthritis and uveitis

27 Mar 2018, 5 p.m.

Researchers from the UCL Great Ormond Street Institute of Child Health (ICH) and Great Ormond Street Hospital (GOSH) will lead a UK-wide effort to drive the development of new, targeted treatments for children and young people with juvenile idiopathic art